At the beginning of the month, I wrote that General Electric
Actually, it’s no big surprise by now
In truth, the cut had already been factored in by investors; based on yesterday’s closing price, the dividend yield on GE shares was 13.6% -- a bit rich to be sustainable. Even at $0.10 per share, the annual dividend yield is 4.4%, or about one and half percentage points above the 10-year Treasury yield.
The reduction in the dividend will produce significant cash savings, approximately $9 billion on an annual basis. The move is also a gesture of goodwill toward the credit rating agencies that are reviewing GE’s rating.
Come on in, you’re on the list
Immelt is eating a little crow over the dividend, but he is simply joining a crowded banquet. The list of companies that have cut their dividends recently reads like a who’s who of corporate America (admittedly, many of them are financials), including JPMorgan Chase
Who’ll be next? Wells Fargo
Numbers speak louder than words
The lesson here is that CEOs are having as much difficulty wrapping their heads around the magnitude of the current crisis as anyone else. Investors can’t rely on executives’ reassurances that a company will maintain its dividend, as these may not be based on an objective assessment of economic fundamentals. However, the numbers don’t lie: Dividend-oriented investors must be extra diligent in analyzing a firm’s financial position and earnings power through the downturn. It’s the only way to avoid being faked out by an over-optimistic CEO.
In this market, dividends -- those that are sustainable -- will be a big component of future shareholder returns. The team at Motley Fool Income Investor can show you how to build -- and manage -- a portfolio of stocks that pay a solid yield. To find out their top five recommendations for new money now, take advantage of a 30-day free trial today.
Alex Dumortier, CFA, has a beneficial interest in Wells Fargo, but not in any of the other companies mentioned in this article. Pfizer and JPMorgan Chase are former Motley Fool Income Investor picks. Pfizer is a Motley Fool Inside Value recommendation. Try any of our Foolish newsletters today, free for 30 days. The Motley Fool has a disclosure policy.